INS and endometrial cancer: Our systematic MR analysis of 14 previously reported molecular risk factors and BMI in 12,906 endometrial cancer cases and 108,979 controls provided evidence for roles of elevated BMI, fasting insulin, total and bioavailable testosterone and SHBG in risk of overall and endometrioid endometrial cancer.